US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
OrthoPediatrics Corporation (KIDS)
OrthoPediatrics Corporation (KIDS) ニュース

OrthoPediatrics Corporation (KIDS)

18.32

0.22

(1.22%)

終了 6月7日 5:00AM

18.32

-0.03

(-0.16%)

取引時間後: 8:00AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Form 8-K - Current report

OrthoPediatrics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

WARSAW, Ind., May 26, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 8-K - Current report

OrthoPediatrics Corp. Reports First Quarter 2026 Financial Results and Increases 2026 Financial Guidance

WARSAW, Ind., April 30, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”...

OrthoPediatrics Expands Specialty Bracing Portfolio with TRAXIO Halo Gravity Traction System

WARSAW, Ind., April 30, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

OrthoPediatrics Corp. to Report First Quarter Financial Results on April 30, 2026

WARSAW, Ind., April 16, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”...

Form 8-K - Current report

OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference

WARSAW, Ind., March 31, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

camelion

camelion 5分前

June flowers 💐!

Flobewan

Flobewan 6分前

Hey, somebody ate all my homemade banana cream ice cream, not only that but they ate all my chocolate/banana cream combo graham cracker crust pie. Now I gotta make more ice cream. Gonna see how chocolate/banana cream ice cream comes out.

And somehow my whole loaf of homemade bread dis

manibiotech

manibiotech 6分前

NICE has always said that they are Liaising with NWBO for years . Sommer is know what’s different that you are claiming ?

US Market News

US Market News 7分前

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using InsulinJune 6, 2026 2:45 PM
Business Wire Dexcom sponsored CONNECT randomized controlled trial expected to help establish new

joe botts

joe botts 7分前

Sorry 6' 1 here! Lol!!!!!!!

manibiotech

manibiotech 7分前

Agreed

If they wanted privacy and silence they should have stayed private and not took public money to pay their salaries and development and denied any accountability to the same public ( aka shareholders )

1plus1

world cup starts in days >> biei /security should be involved >>https://www.fifa.com/en/tournaments/mens/worldcup/canadamexicousa2026/mexico/mexico-city

jimr1717

jimr1717 8分前

Has updated timeline 39Z-4 been updated?

researcher59

researcher59 10分前

SPCX - retail shares are not restricted, but Fidelity may limit access to futures IPOs for those who flip their shares in under 15 days.

The IPO may be oversubscribed, so if you ask for 50 shares you might only get 25.

https://www.businessinsider.com/spacex-ipo-fidelity

JimmyRich

JimmyRich 11分前

🙏🏼🙏🏼🙏🏼 my friend

bbotcs

bbotcs 11分前

INTU is near its 52-week low. If the perception among hedge fund managers and other institutional investors is that AI is going to hurt Intuit, it is going to stay down, imo.
The company needs a strong AI strategy.
Also, the dividend yield is not good. IMO, investors are not getting

Doc logic

Doc logic 13分前

brazen22,

That is certainly one way of thinking. I personally don’t have a problem with that but there still remains the bigger picture to consider. In my view “the process” and the framework it is built on is the problem creating this kind of dilemma that all parties are required t

walterc

walterc 13分前

th6565. what is your nationality?

jimr1717

jimr1717 16分前

“Although Wertheim & Co. no longer exists as an independent entity” ❌

Only Fools are Fooled

https://wertheimandcompany.com/transactions/

Top Penny

Top Penny 16分前

Why not? Because you are short and nobody can make coin except you? Try again because you lose here pal!!!

Top Penny

Top Penny 17分前

Within in the next 30 days IMO, soon trips are history for good!!!

Top Penny

Top Penny 18分前

Lve

What do you think the price will go to?

joe botts

joe botts 20分前

prowler3701

prowler3701 20分前

Are we still in the quiet period?? LOL!!

Are we still the game changing, jaw dropping, next Lionsgate, tentpole movie, myflix tail that wags the dog, unbelievable movie distributor lol.

17 years of failure buffoon boy CEO.

Jack Wagon CEO!!

richme

richme 20分前

Guess there is the problem of numbers in the clientele realm??

flipper44

flipper44 21分前

It’s been half a year since the ASM. It’s been over two and a half years since the MAA was submitted. It’s been two decades since the phase iii trial appeared on clinicaltrials.gov.

It’s great they are all around the world advocating for cancer vaccines, but we need an update. We

Lve

DewDiligence

DewDiligence 22分前

Berobenatide—dosed monthly—appears_competitive_with_weekly Zepbound/Wegovy in efficacy/tolerability—see slide 7 at the link in #msg-177679183.

US Market News

US Market News 22分前

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complicationsJune 6, 2026 2:30 PM
PR Newswire (US)

OrthoPediatrics

American Financial

Golden Sun Technology

Harbor Disciplined Bond ...

Gulfport Energy

Millennium Services

Compass EMP U.S. Discove...

CSLM Acquisition

Resolution Minerals

Exro Technologies

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。